Increased Number of White Matter Lesions in Patients with Familial Cerebral Cavernous Malformations

REFERENCES

1. 1.↵
   2. Rivera PP,
   3. Willinsky RA,
   4. Porter PJ

   . Intracranial cavernous malformations. Neuroimaging Clin N Am 2003;13:27–40

   CrossRefPubMed
2. 2.↵
   2. Kattapong VJ,
   3. Hart BL,
   4. Davis LE

   . Familial cerebral cavernous angiomas: clinical and radiologic studies. Neurology 1995;45:492–97

   CrossRef
3. 3.↵
   2. Gunel M,
   3. Awad IA,
   4. Finberg K, et al

   . A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 1996;334:946–51

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Zabramski JM,
   3. Wascher TM,
   4. Spetzler RF, et al

   . The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422–32

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Akers AL,
   3. Ball KL,
   4. Clancy M, et al

   . Brain vascular malformation consortium: overview, progress and future directions. J Rare Disord 2013;1:5

   PubMed
6. 6.↵
   2. Christiansen P,
   3. Larsson HB,
   4. Thomsen C, et al

   . Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 1994;35:117–22

   Abstract/FREE Full Text
7. 7.↵
   2. Vernooij MW,
   3. Ikram MA,
   4. Tanghe HL, et al

   . Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821–28

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Osborn AG

   . Osborn's Brain: Imaging, Pathology, and Anatomy. Salt Lake City: Amirsys; 2012
9. 9.↵
   2. Liao D,
   3. Cooper L,
   4. Cai J, et al

   . Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control: the ARIC Study—Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262–70

   Abstract/FREE Full Text
10. 10.↵
    2. Hopkins RO,
    3. Beck CJ,
    4. Burnett DL, et al

    . Prevalence of white matter hyperintensities in a young healthy population. J Neuroimaging 2006;16:243–51

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Katzman GL,
    3. Dagher AP,
    4. Patronas NJ

    . Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999;282:36–39

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Eriksson SH,
    3. Stepney A,
    4. Symms MR, et al

    . Ultra-fast low-angle rapid acquisition and relaxation enhancement (UFLARE) in patients with epilepsy. Neuroradiology 2001;43:1040–45

    CrossRefPubMed
13. 13.↵
    2. Jansen JFA,
    3. Vlooswijk MC,
    4. Majoie HM, et al

    . White matter lesions in patients with localization-related epilepsy. Invest Radiol 2008;43:552–58

    CrossRefPubMed
14. 14.↵
    2. Wieshmann UC

    . Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatry 2003;74:466–70

    Abstract/FREE Full Text
15. 15.↵
    2. Stockton RA,
    3. Shenkar R,
    4. Awad IA, et al

    . Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 2010;207:881–96

    Abstract/FREE Full Text
16. 16.↵
    2. Glading A,
    3. Han J,
    4. Stockton RA, et al

    . KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 2007;179:247–54

    Abstract/FREE Full Text
17. 17.↵
    2. Schneider H,
    3. Errede M,
    4. Ulrich NH, et al

    . Impairment of tight junctions and glucose transport in endothelial cells of human cerebral cavernous malformations. J Neuropathol Exp Neurol 2011;70:417–29

    CrossRefPubMed
18. 18.↵
    2. Tu J,
    3. Stoodley MA,
    4. Morgan MK, et al

    . Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J Neurosurg 2005;103:903–09

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Clatterbuck RE,
    3. Eberhart CG,
    4. Crain BJ, et al

    . Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 2001;71:188–92

    Abstract/FREE Full Text
20. 20.↵
    2. Hart BL,
    3. Taheri S,
    4. Rosenberg GA, et al

    . Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations. Trans Stroke Res 2013;4:500–06

    CrossRef
21. 21.↵
    2. Young VG,
    3. Halliday GM,
    4. Kril JJ

    . Neuropathologic correlates of white matter hyperintensities. Neurology 2008;71:804–11

    CrossRef